Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Net Cash Flow (2012 - 2026)

Precigen (PGEN) posted quarterly Net Cash Flow of -$22.8 million for Q1 2026, up 3.03% year-over-year from -$22.1 million in Q1 2025, and down 243.16% quarter-over-quarter from $15.9 million in Q4 2025.

Analysis

Precigen (PGEN) Net Cash Flow (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Net Cash Flow for 15 consecutive years, with -$22.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Cash Flow rose 3.03% year-over-year to -$22.8 million; the TTM figure through Mar 2026 stood at $1.4 million (up 111.88% YoY), while the FY2025 annual figure was $682000.0, down 96.86% from the prior year.
  • Net Cash Flow slipped to -$22.8 million in Q1 2026 per PGEN's latest filing, from $15.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $42.3 million in Q3 2022 and bottomed at -$43.3 million in Q4 2022.
  • Historically, Net Cash Flow has averaged -$2.0 million across 5 years, with a median of -$2.4 million in 2022.
  • On a YoY basis, Net Cash Flow climbed as much as 709.72% in 2022 and fell as far as 3616.83% in 2022.
  • Precigen's Net Cash Flow stood at -$43.3 million in 2022, then jumped by 94.28% to -$2.5 million in 2023, then jumped by 293.85% to $4.8 million in 2024, then surged by 231.5% to $15.9 million in 2025, then plunged by 243.16% to -$22.8 million in 2026.
  • Business Quant data shows PGEN's Net Cash Flow at -$22.8 million in Q1 2026, $15.9 million in Q4 2025, and $552000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn 8.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.85 Mn
Mar 31, 2026 -22.75 Mn
Dec 31, 2025 15.89 Mn
Sep 30, 2025 552,000.00
Jun 30, 2025 7.70 Mn
Mar 31, 2025 -23.46 Mn
Dec 31, 2024 4.79 Mn
Sep 30, 2024 15.05 Mn
Jun 30, 2024 -8.10 Mn
Mar 31, 2024 9.96 Mn
Dec 31, 2023 -2.47 Mn
Sep 30, 2023 -6.48 Mn
Jun 30, 2023 -6.85 Mn
Mar 31, 2023 -24.62 Mn
Dec 31, 2022 -43.26 Mn
Sep 30, 2022 42.31 Mn
Jun 30, 2022 9.41 Mn
Mar 31, 2022 -2.38 Mn
Dec 31, 2021 1.23 Mn
Sep 30, 2021 5.23 Mn